SignatureFD
IMNM icon

SignatureFD’s Immunome IMNM Stock Holding History

SignatureFD’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.39K Hold
204
– – ﹤0.01% 2980
2026
Q2 		$4.32K Hold
204
– – ﹤0.01% 2901
2026
Q1 		$4.46K Hold
204
– – ﹤0.01% 2817
2025
Q4 		$4.38K Hold
204
– – ﹤0.01% 2740
2025
Q3 		$2.39K Hold
204
– – ﹤0.01% 2901
2025
Q2 		$1.9K Buy
+204
New +$1.67K ﹤0.01% 2881
2025
Q1 		– Sell
-13
Closed -$138 – 3373
2024
Q4 		$138 Sell
13
-71
-85% -$858 ﹤0.01% 3240
2024
Q3 		$1.23K Buy
+84
New +$1.19K ﹤0.01% 2955

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Alerus Financial
Alerus Financial Grand Forks, North Dakota $2.27B AUM 22.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SignatureFD's IMNM Position: Q3 2026 in Review

SignatureFD held its Immunome (IMNM) position steady in Q3 2026 at 204 shares worth $4.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2980.

SignatureFD first reported a position in IMNM in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.46K in Q1 2026. 84 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • SignatureFD held 204 shares of Immunome worth $4.39K as of Q3 2026.
  • SignatureFD left its Immunome share count unchanged in Q3 2026.
  • Immunome made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2980 holding.
  • SignatureFD first reported a position in Immunome in Q3 2024 and has held it in 8 quarters since.
  • SignatureFD's Immunome position peaked at $4.46K in Q1 2026.
  • 84 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.